Sari, I.K. et al. 2025. Preclinical Evaluation of HPV Type 52 L1L2 Chimeric Protein as a Cervical Cancer Vaccine Candidate. HAYATI Journal of Biosciences. 33, 3 (Dec. 2025), 556–565. DOI:https://doi.org/10.4308/hjb.33.3.556-565.